Characteristics of patients with intestinal Behçet's disease requiring treatment with immunosuppressants or anti-TNFα antibody

References

• Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, et al. EULAR recommendations for the management of Behcet disease . Ann Rheum Dis. 2008;67(12):1656–62, doi:10.1136/ard.2007.080432.
   PubMed Web of Science ®Google Scholar
• International Team for the Revision of the International Criteria for Behcet's D. The International Criteria for Behcet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28(3):338–47, doi:10.1111/jdv.12107.
   PubMed Web of Science ®Google Scholar
• Suzuki Kurokawa M, Suzuki N. Behcet's disease. Clin Exp Med. 2004;4(1):10–20.
   PubMed Web of Science ®Google Scholar
• Iida M, Kobayashi H, Matsumoto T, Okada M, Fuchigami T, Yao T, Fujishima M, et al. Postoperative recurrence in patients with intestinal Behcet's disease. Dis Colon Rectum. 1994;37(1):16–21.
   PubMed Web of Science ®Google Scholar
• Choi IJ, Kim JS, Cha SD, Jung HC, Park JG, Song IS, Kim CY. Long-term clinical course and prognostic factors in intestinal Behcet's disease. Dis Colon Rectum. 2000;43(5):692–700.
   PubMed Web of Science ®Google Scholar
• Kram MT, May LD, Goodman S Molinas S. Behcet's ileocolitis: successful treatment with tumor necrosis factor-alpha antibody (infliximab) therapy: report of a case. Dis Colon Rectum. 2003;46(1): 118–21, doi:10.1097/01.DCR.0000044733.59705.44.
   PubMed Web of Science ®Google Scholar
• Hassard PV, Binder SW, Nelson V Vasiliauskas EA. Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behcet's disease: a case report. Gastroenterology. 2001;120(4): 995–9.
   PubMed Web of Science ®Google Scholar
• Hisamatsu T, Ueno F, Matsumoto T, Kobayashi K, Koganei K, Kunisaki R, et al. The 2nd edition of consensus statements for the diagnosis and management of intestinal Behcet's disease: indication of anti-TNFalpha monoclonal antibodies. J Gastroenterol. 2014;49(1): 156–62, doi:10.1007/s00535-013-0872-4.
   PubMed Web of Science ®Google Scholar
• Jung YS, Cheon JH, Park SJ, Hong SP, Kim TI, Kim WH. Clinical course of intestinal Behcet's disease during the first five years. Dig Dis Sci. 2013;58(2):496–503, doi:10.1007/s10620-012-2351-9.
   PubMed Web of Science ®Google Scholar
• Jung YS, Yoon JY, Hong SP, Kim TI, Kim WH, Cheon JH. Influence of age at diagnosis and sex on clinical course and long-term prognosis of intestinal Behcet's disease. Inflamm Bowel Dis. 2012;18(6): 1064–71, doi:10.1002/ibd.21833.
   PubMed Web of Science ®Google Scholar
• Chung MJ, Cheon JH, Kim SU, Park JJ, Kim TI, Kim NK, Kim WH. Response rates to medical treatments and long-term clinical outcomes of nonsurgical patients with intestinal Behcet disease . J Clin Gastroenterol. 2010;44(6):e116–22, doi:10.1097/MCG.0b013e3181c8a50f.
   Google Scholar
• Jung YS, Hong SP, Kim TI, Kim WH, Cheon JH. Long-term clinical outcomes and factors predictive of relapse after 5-aminosalicylate or sulfasalazine therapy in patients with intestinal Behcet disease. J Clin Gastroenterol. 2012;46(5):e38–45, doi:10.1097/MCG.0b013e3182431d56.
   Google Scholar
• Wolters FL, Russel MG, Sijbrandij J, Ambergen T, Odes S, Riis L, et al. Phenotype at diagnosis predicts recurrence rates in Crohn's disease . Gut. 2006;55(8):1124–30, doi:10.1136/gut.2005.084061.
   PubMed Web of Science ®Google Scholar
• Keh C, Shatari T, Yamamoto T, Menon A, Clark MA, Keighley MR. Jejunal Crohn's disease is associated with a higher postoperative recurrence rate than ileocaecal Crohn's disease. Colorectal Dis. 2005;7(4):366–8, doi:10.1111/j.1463-1318.2005.00766.x.
   PubMed Web of Science ®Google Scholar
• Thia KT, Sandborn WJ, Harmsen WS, Zinsmeister AR, Loftus EV Jr. Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort. Gastroenterology. 2010;139(4):1147–55, doi:10.1053/j.gastro.2010.06.070.
   PubMed Web of Science ®Google Scholar
• Chou SJ, Chen VT, Jan HC, Lou MA Liu YM. Intestinal perforations in Behcet's disease. J Gastrointest Surg. 2007;11(4):508–14, doi:10.1007/s11605-006-0031-9.
   PubMed Web of Science ®Google Scholar
• Takada Y, Fujita Y, Igarashi M, Katsumata T, Okabe H, Saigenji K, et al. Intestinal Behcet's disease–pathognomonic changes in intramucosal lymphoid tissues and effect of a “rest cure” on intestinal lesions. J Gastroenterol. 1997;32(5):598–604.
   PubMed Web of Science ®Google Scholar
• Lee CR, Kim WH, Cho YS, Kim MH, Kim JH, Park IS, et al. Colonoscopic findings in intestinal Behcet's disease . Inflamm Bowel Dis. 2001;7(3):243–9.
   PubMed Web of Science ®Google Scholar
• Kikuchi H. Clinical characteristics of Intestinal Behcet's disease (in Japanese). Igaku no ayumi. 2005;215(1 ):73–6.
   Google Scholar
• Ahmad T, Wallace GR, James T, Neville M, Bunce M, Mulcahy-Hawes K, et al. Mapping the HLA association in Behcet's disease: a role for tumor necrosis factor polymorphisms? Arthritis Rheum. 2003;48(3):807–13, doi:10.1002/art.10815.
   PubMed Web of Science ®Google Scholar
• Sano K, Yabuki K, Imagawa Y, Shiina T, Mizuki N, Ohno S, et al. The absence of disease-specific polymorphisms within the HLA-B51 gene that is the susceptible locus for Behcet's disease. Tissue antigens. 2001;58(2):77–82.
   PubMed Web of Science ®Google Scholar
• de Menthon M, Lavalley MP, Maldini C, Guillevin L, Mahr A. HLA-B51/B5 and the risk of Behcet's disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum. 2009;61(10):1287–96, doi:10.1002/art.24642.
   PubMed Web of Science ®Google Scholar
• Aramaki K, Kikuchi H, Hirohata S. HLA-B51 and cigarette smoking as risk factors for chronic progressive neurological manifestations in Behcet's disease. Mod Rheumatol. 2007;17(1):81–2, doi:10.1007/s10165-006-0541-z.
   PubMedGoogle Scholar
• Maldini C, Lavalley MP, Cheminant M, de Menthon M Mahr A. Relationships of HLA-B51 or B5 genotype with Behcet's disease clinical characteristics: systematic review and meta-analyses of observational studies. Rheumatology. 2015;51(5):887–900, doi:10.1093/rheumatology/ker428.
   Web of Science ®Google Scholar